NextUp: The Local Company Unlocking the Mysteries of Brain Disease

June 30, 2020

Who: Maria Maccecchini was a young scientist in her early twenties when she first became fascinated with the idea of cell death, the process through which human cells stop functioning. At the time, science students like Maccecchini were taught that while most human cells, like skin cells, can divide or replace themselves many times before […]

Read More

Wistar Institute Will use 3D-Printed Lung Models Made by Allevi for Coronavirus Research

June 30, 2020

Pennovation-based life sciences technology company Allevi is partnering with University City-based biomedical research center The Wistar Institute to use 3D printing to learn about COVID-19. COVID-19 is an acute respiratory illness and has taken more than 500,000 lives worldwide. Allevi’s patented 3D bioprinting platform will create 3D models of lungs for Wistar scientists to use […]

Read More

University of Kentucky, Children’s Hospital of Philadelphia and Mitochon Pharmaceuticals Awarded NIH Grant for Traumatic Brain Injury Studies

June 23, 2020

Mitochon Pharmaceuticals today announced that they, in partnership with the University of Kentucky (UK) and Children’s Hospital of Philadelphia (CHOP), were awarded a $3.2M National Institutes of Health grant to study Mitochon’s mitochondrial targeted drug therapies for treating Traumatic Brain Injury (TBI). This important award, along with the Company’s open IND, will help pave the […]

Read More

The Mobil-Aider Takes the Guessing Out of Joint Assessment

May 18, 2020

The Mobil-Aider2 is an innovative orthopedic device that permits clinicians to address a “pain point” through the quantification of joint linear translation. This impacts the ability to accurately assess joint injuries and provide consistent, efficacious treatments to enhance injury recovery. As a first to market device for these tasks, the Mobil-Aider will allow the development […]

Read More

Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment

April 23, 2020

WAYNE, Pa.–(BUSINESS WIRE)– Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating below-the-knee (BTK) lesions. The Serranator device is the first and only angioplasty balloon FDA Cleared and CE Marked that embeds serration technology into a semi-compliant […]

Read More

Watch the Webinar: “PRIMA: Why Medical Product Development Starts at Commercialization”

April 2, 2020

Eric Sugalski, CEO of Archimedic, led an interactive, case study based workshop focused on: How to identify the most critical commercial risks facing your medtech business How to turn nascent medtech ideas into comprehensive business focused solutions How to build a product development and commercialization plan that secures the investment needed to advance your medtech […]

Read More

Coronavirus Test Available Now as COVID-19 Spreads Worldwide

March 13, 2020

In the time of the virus, it is as important as ever to remain calm and practice preventative measures. At the time of writing, WHO characterized COVID-19 (Coronavirus Disease 2019) as a pandemic and has infected over 120,000 people with over 4,000 casualties. With that said, over 66,000 people with confirmed cases of COVID-19 have […]

Read More

New Genomic Tests Aim to Diagnose Deadly Infections Faster

February 24, 2020

Rapid genomic tests are poised to change the way doctors diagnose and treat infections, but their cost may limit widespread use. Ryan Springer’s mystery illness began last summer with a dull ache in his chest. Over the next few days, the symptoms grew more alarming: sharp pain with every breath, a rapid heartbeat and a […]

Read More

Inside Annovis Bio’s $13.8 Million IPO

February 5, 2020

Maria Maccecchini made no effort to hide her glee a day after her company completed a multimillion-dollar initial public stock offering. “We aren’t cash-strapped anymore,” said the founder and CEO of Annovis Bio, greeting a visitor at her Chester County office. Annovis ended up raising a total of $13.8 million from its IPO, which closed […]

Read More

Smithfield Foods Taps Montco Animal Health Firm to Save its Bacon

January 14, 2020

MBF Therapeutics Inc., a Montgomery County company developing DNA-based immunotherapeutic vaccines for animals, has signed an agreement with Smithfield Foods to collaborate on new swine vaccines. Their goal is to develop swine vaccines with the potential to reduce the use of antibiotics in pork production and chronic disease in pigs by eliciting responses in both […]

Read More